Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Jordan Winter, MD

Jordan Winter, MD

  • Director, Surgical Services, UH Seidman Cancer Center
  • Division Chief, Surgical Oncology, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine
  • Jerome A. and Joy Weinberger Family Master Clinician in Surgical Oncology, UH Seidman Cancer Center
  • John and Peggy Garson Family Endowed Chair in Pancreatic Cancer Research, UH Seidman Cancer Center
  • Specialty: Surgical Oncology, General Surgery
  • Location:
    UH Fairlawn Health Center
    3800 Embassy Pkwy
    Fairlawn, OH 44333

Biography: Jordan Winter, MD

Expertise

  • Abdominal Sarcoma
  • Bile Duct Strictures
  • Biliary Cancer
  • Chronic Pancreatitis
  • Gastric Cancer
  • Liver Cancers
  • Pancreatic and Related Cancers
  • Pancreatic Cysts

Certifications & Memberships

  • Surgery - American Board of Surgery

Education

Fellowship | Surgical Oncology
Surgical Oncology - Memorial Sloan-Kettering Cancer Center (2009 - 2011)

Residency | General Surgery
General Surgery - Johns Hopkins Hospital (2007 - 2009)

Research Fellowship | Surgical Oncology
Surgical Oncology - Johns Hopkins Hospital (2004 - 2007)

Residency | General Surgery
General Surgery - Johns Hopkins Hospital (2001 - 2004)

Medical Education
Weill Cornell Medical College (2001)

Undergraduate
Princeton University (1997)

About

Member, GI Cancer Genetics Program, Case Comprehensive Cancer Center

Jordan M. Winter, MD is a nationally recognized, board-certified surgeon with a special interest in the medical and surgical management of pancreatic and related cancers, pancreatic cysts, chronic pancreatitis, bile duct strictures, biliary, gastric and liver cancers and abdominal tumors.

In addition to being a highly skilled clinician, Dr. Winter is a leader in translational and basic research. As director of the Winter Lab, which is funded by the American Cancer Society and the NIH, he is at the forefront of investigational efforts to find alternative treatments for pancreatic cancer. The lab seeks to understand how pancreatic cancer cells survive in their microenvironment and identify their metabolic weaknesses to ultimately discover new and effective therapies. A clinical study will soon be underway to study the use of a novel metabolic inhibitor.

With 18 years of experience, Dr. Winter has made significant contributions to his field of study and has authored more than 100 peer-reviewed articles and a dozen book chapters, many of which focus on pancreatic cancer. He excels in his role as educator and is committed to helping his colleagues reach their professional goals.

Dr. Winter uses a unique blend of science and compassion in his approach to health care and has dedicated his career to helping patients who face the most challenging cancers. With two office locations in Cleveland and Beachwood, patients across the region have convenient access to his expertise. He also consults with people across the country through UH’s unique Telehealth program.

Dr. Winter has an impressive educational background. He received his undergraduate degree from Princeton University in 1997 and his medical degree from Weill Cornell Medical College in New York, graduating in 2001. After completing a general surgery residency at Johns Hopkins Hospital in Baltimore, Dr. Winter further honed his expertise at Memorial Sloan-Kettering Cancer Center in New York, where he completed a two-year fellowship in surgical oncology.

Featured Videos

Watch to find out more about this University Hospitals physician.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Jordan Winter did not disclose any Outside Relationships with Industry.